🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Status
Unknown
Location
Cancer institute
Start Date
2016-12
Trial ID
NCT03123770
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
The purpose of this study is to determine how many pathological complete re...
Status
Unknown
Location
Hospital de Hospitalet
Start Date
2008-01
Trial ID
NCT00721747
Treatments Being Tested
Breast cancer is the most common malignant tumor in women. EC-TH is one of ...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2019-01-10
Trial ID
NCT04172259
To evaluate the safety and efficacy of pegylated liposomal doxorubicin/cycl...
Status
Unknown
Location
Shanghai Pudong Hospital
Start Date
2021-07-01
Trial ID
NCT05656079
Treatments Being Tested
RATIONALE: Studying samples of blood and tumor tissue from patients with ca...
Status
Terminated
Location
Unversity of Nebraska Medical Center
Start Date
2004-04-15
Trial ID
NCT00665457
Treatments Being Tested
This is a multicenter, open label, non-inferiority, randomized controlled c...
Status
Recruiting
Location
Sunyat-sen Memorial Hospital
Start Date
2021-12-20
Trial ID
NCT05159193
Phase II, randomized, open-label, international, multicenter study to compa...
Status
Active Not Recruiting
Location
Complejo Hospitalario Universitario de Santiago (CHUS)
Start Date
2020-10-02
Trial ID
NCT04293393
Treatments Being Tested
Anthracycline-paclitaxel sequential combination therapy is the standard reg...
Status
Unknown
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2022-05-01
Trial ID
NCT05302336
Treatments Being Tested
To evaluate the efficacy and safety of treatment with MYOCET® (doxorubicin ...
Status
Completed
Location
Teva Investigational Site 16
Start Date
2008-10-13
Trial ID
NCT00712881